Hong-Tao Hu

Chemoembolization for Hepatocellular Carcinoma: Multivariate Analysis of Predicting Factors for Tumor Response and Survival in a 362-Patient Cohort

Hong-Tao Hu, Jin Hyoung Kim, Lim-Sick Lee et al. · Journal of Vascular and Interventional Radiology · 2011 · 100 citations · Full text

Medicine, Oncology, Pharmacology +14

Tumor vascularity and lipiodol deposition as early radiological markers for predicting risk of disease progression in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization

Chengshi Chen, Fangkun Li, Chenyang Guo et al. · Oncotarget · 2016 · 41 citations · Full text

Medicine, Oncology, Radiology +17

Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial

Ying–Hong Shi, Guohong Han, Jian Zhou et al. · ˜The œLancet. Gastroenterology & hepatology · 2025 · 39 citations

Medicine, Oncology, Pharmacology +10

Arsenic trioxide intravenous infusion combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with pulmonary metastasis: Long‐term outcome analysis

Hong-Tao Hu, Quan Jun Yao, Yan Li Meng et al. · Journal of Gastroenterology and Hepatology · 2016 · 35 citations

Medicine, Oncology, Surgery +17

Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Transarterial Chemoembolization and Sorafenib vs.125Iodine Implantation

Hong-Tao Hu, Junpeng Luo, Guangshao Cao et al. · Frontiers in Oncology · 2021 · 26 citations · Full text

Medicine, Oncology, Surgery +17